SHLT (SHL Telemedicine) YoY EBITDA Growth : -69.96% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is SHL Telemedicine YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. SHL Telemedicine's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -69.96%.

SHL Telemedicine's EBITDA per Share for the six months ended in Jun. 2024 was $0.07.

SHL Telemedicine YoY EBITDA Growth Historical Data

The historical data trend for SHL Telemedicine's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine YoY EBITDA Growth Chart

SHL Telemedicine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-43.00

-39.77

-204.08

216.42

-70.19

SHL Telemedicine Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial															83.61	145.17	-33.63	-109.58	-69.96

SHL Telemedicine YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

SHL Telemedicine's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.186	-	0.624)	/	\| 0.624 \|
=	-70.19 %

SHL Telemedicine's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(0.067	-	0.223)	/	\| 0.223 \|
=	-69.96 %

SHL Telemedicine YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

SHL Telemedicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (NAS:SHLT) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

SHLTN:Switzerland

Address

90 Yigal Alon Street, Tel Aviv, ISR, 67891

Website

https://www.shl-telemedicine.com

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.